新生血管性年龄相关性黄斑变性眼中视网膜色素上皮脱离的优化管理
本综述基于文献证据评估新生血管性年龄相关性黄斑变性(nAMD)中视网膜色素上皮脱离(PED)的最佳管理。抗血管内皮生长因子(VEGF)治疗对继发于nAMD的PED有效,不同抗VEGF治疗视觉结局相似,更高剂量可能改善解剖反应但与视力改善无相关性。作者认为治疗应关注视力获益而非PED完全消退。
要点
- 抗VEGF治疗对继发于nAMD的PED安全有效,不同抗VEGF药物视觉结局相似。
- 较高抗VEGF剂量可能改善解剖反应,但与视力改善无相关性。
- 纤维血管性PED可能较难治疗,但即使这类眼仍可通过抗VEGF治疗获得视力。
核心结论
- 现有文献提示抗VEGF治疗对PED合并nAMD安全有效。
- 治疗应关注视力获益而非PED消退,因为多数PED合并nAMD眼中解剖与功能改善无明显相关性。
研究设计与样本
- 本综述通过全面文献回顾,评估以往评估nAMD中PED治疗的回顾性和前瞻性研究。
主要发现
- 研究显示抗VEGF治疗对继发于nAMD的PED眼有效。
- 不同抗VEGF治疗的视觉结局相似。
- 较高抗VEGF剂量可能改善解剖反应,但与视力改善无相关性。
- 纤维血管性PED可能较难治疗,但即使这类眼仍可通过抗VEGF治疗获得视力。
- 抗VEGF治疗后15%至20%的PED眼可发生视网膜色素上皮撕裂,尤其是高度大于500 µm至600 µm的PED;但继续治疗视力可能稳定。
关键数值与推荐
- 抗VEGF治疗后15%至20%的PED眼可发生视网膜色素上皮撕裂。
- 视网膜色素上皮撕裂尤其见于高度大于500 µm至600 µm的PED。
临床怎么用
- 作者认为抗VEGF治疗对PED合并nAMD安全有效。
- 作者认为治疗应关注视力获益而非PED消退,因为多数PED合并nAMD眼中解剖与功能改善无明显相关性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This review aimed to determine the optimal management of retinal pigment epithelial detachments (PEDs) in neovascular age-related macular degeneration (nAMD) based on review of available evidence in the literature. METHODS: A comprehensive literature review evaluates previous retrospective and prospective studies that assessed the treatment of PEDs in nAMD. RESULTS: Studies illustrated that anti-vascular endothelial growth factor (VEGF) therapy can be effective in eyes with PED secondary to nAMD. Similar visual outcomes are associated with different anti-VEGF treatments. Higher anti-VEGF doses may improve anatomical response, without correlation with vision improvement. Fibrovascular PEDs may be difficult to treat, but even these eyes can gain vision with anti-VEGF therapy. A retinal pigment epithelial tear may develop in 15% to 20% of eyes with PEDs after anti-VEGF therapy, especially in PEDs greater than 500 µm to 600 µm in height; however, vision may stabilize with continued therapy. Atrophy may complicate eyes with PED and nAMD after anti-VEGF therapy, especially in association with complete PED resolution. CONCLUSION: Available literature suggests that anti-VEGF therapy is safe and efficacious for PED and nAMD. Treatment should focus on vision gains rather than PED resolution because there is no apparent correlation between anatomical and functional improvement in most eyes with PED and nAMD.
引用
- Khanani AM, Eichenbaum D, Schlottmann PG, et al. OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2018. PMID: 29697591. doi:10.1097/IAE.0000000000002195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。